| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic Review
|
Jelicic, Jelena
|
|
|
22 |
11 |
p. e981-e991
|
article
|
| 2 |
Cost-Effectiveness of PET Directed Versus Combined Modality Therapy for Early-Stage Favorable Hodgkin's Lymphoma
|
Smith, Clayton P.
|
|
|
22 |
11 |
p. e992-e999
|
article
|
| 3 |
CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment
|
Swan, D.
|
|
|
22 |
11 |
p. 847-852
|
article
|
| 4 |
Editorial Board
|
|
|
|
22 |
11 |
p. A1-A2
|
article
|
| 5 |
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials
|
Dixon, Jesse G.
|
|
|
22 |
11 |
p. e1009-e1018
|
article
|
| 6 |
High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments
|
Fernandez, Nicolas
|
|
|
22 |
11 |
p. 853-862
|
article
|
| 7 |
Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations
|
Yasuda, Hajime
|
|
|
22 |
11 |
p. 805-811
|
article
|
| 8 |
Impact of Chronic Kidney Disease and Acute Kidney Injury on Safety and Outcomes of CAR T-Cell Therapy in Lymphoma Patients
|
Ahmed, Gulrayz
|
|
|
22 |
11 |
p. 863-868
|
article
|
| 9 |
Longitudinal Real-World Neuropathy and Patient-Reported Outcomes With Bortezomib and Lenalidomide in Newly Diagnosed Multiple Myeloma
|
Major, Ajay
|
|
|
22 |
11 |
p. e1000-e1008
|
article
|
| 10 |
Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements
|
Bliven, Sean Patrick
|
|
|
22 |
11 |
p. 825-834
|
article
|
| 11 |
Pediatric Plasma Cell Neoplasms: A Population-Based Study
|
Loap, Pierre
|
|
|
22 |
11 |
p. 841-846
|
article
|
| 12 |
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma
|
Yoon, Sang Eun
|
|
|
22 |
11 |
p. e972-e980
|
article
|
| 13 |
Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke
|
Narezkina, Anna
|
|
|
22 |
11 |
p. e959-e971
|
article
|
| 14 |
Retrospective Analysis of the Efficacy and Tolerability of Gemcitabine-Based Chemotherapy in Relapsed/Refractory Lymphoma Patients Not Eligible for Stem Cell Transplant
|
Chiu, May
|
|
|
22 |
11 |
p. 835-840
|
article
|
| 15 |
SOHO State of the Art Updates and Next Questions | Asparaginase—Understanding and Overcoming Toxicities in Adults with ALL
|
Aldoss, Ibrahim
|
|
|
22 |
11 |
p. 787-794
|
article
|
| 16 |
SOHO State of the Art Updates and Next Questions | Mechanisms of Resistance to BCL2 Inhibitor Therapy in Chronic Lymphocytic Leukemia and Potential Future Therapeutic Directions
|
Bennett, Rory
|
|
|
22 |
11 |
p. 795-804
|
article
|
| 17 |
Table of Contents
|
|
|
|
22 |
11 |
p. A3-A5
|
article
|
| 18 |
Treatment Landscape of Relapsed/Refractory Mantle Cell Lymphoma: An Updated Review
|
Al-Mansour, Mubarak
|
|
|
22 |
11 |
p. e1019-e1031
|
article
|
| 19 |
Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen–Results of a Real-Life Study From a Middle-Income Country
|
Lage, Luís Alberto de Pádua Covas
|
|
|
22 |
11 |
p. 812-824
|
article
|
Journal description